Compare NVAX & SMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NVAX | SMX |
|---|---|---|
| Founded | 1987 | N/A |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Industrial Machinery/Components |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.2B |
| IPO Year | 1996 | N/A |
| Metric | NVAX | SMX |
|---|---|---|
| Price | $9.25 | $34.20 |
| Analyst Decision | Hold | |
| Analyst Count | 9 | 0 |
| Target Price | ★ $10.78 | N/A |
| AVG Volume (30 Days) | ★ 3.8M | 2.4M |
| Earning Date | 04-07-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 77.26 | N/A |
| EPS | ★ 2.53 | N/A |
| Revenue | ★ $682,162,000.00 | N/A |
| Revenue This Year | $58.91 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $3.68 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $5.01 | $0.75 |
| 52 Week High | $10.63 | $490.00 |
| Indicator | NVAX | SMX |
|---|---|---|
| Relative Strength Index (RSI) | 58.44 | 52.18 |
| Support Level | $8.01 | $1.79 |
| Resistance Level | $10.42 | $490.00 |
| Average True Range (ATR) | 0.55 | 5.38 |
| MACD | 0.01 | 4.85 |
| Stochastic Oscillator | 79.50 | 46.71 |
Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from the United States.
SMX (Security Matters) PLC provides one solution to solve both authentication and track and trace challenges in order to uphold supply chain integrity and provide quality assurance and brand accountability to producers of goods. Its technology works as a track and trace system using a marker, a reader, and an algorithm to identify embedded sub-molecular particles in order to track and trace different components along a production process (or any other marked good along a supply chain) to the end producer.